Average Co-Inventor Count = 7.90
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (22 from 3,924 patents)
2. Xention Limited (6 from 22 patents)
3. Bayer Aktiengesellschaft (1 from 12,167 patents)
4. Bayer Schering Pharma Ag (1 from 192 patents)
5. Bayer Healthcare Aktiengesellschaft (1 from 77 patents)
6. Bausch + Lomb Ireland Limited (1 from 33 patents)
32 patents:
1. 12290517 - Formulations of 4-(7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile
2. 12129246 - Hydroquinazoline derivatives for the treatment of a disease or disorder
3. 11478480 - Formulations of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile
4. 11234982 - Methods for treating ocular surface pain
5. 10550102 - Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators
6. 10537563 - Methods for treating ocular disease using inhibitors of CSF-1R
7. 10208018 - Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators
8. 9957254 - Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
9. 9867811 - Method of treating atherosclerosis in high triglyceride subjects
10. 9765067 - Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
11. 9603819 - Substituted aminobutyric derivatives as neprilysin inhibitors
12. 9006249 - Substituted aminobutyric derivatives as neprilysin inhibitors
13. 8877815 - Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
14. 8759365 - Organic compounds
15. 8642635 - Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors